A research suggests that the physical benefits of this annual fast, Ramadan; may be far more profound than previously understood — offering what scientists call “short-term protection against cardiometabolic problems” for people struggling with overweight and obesity.
study in the prestigious journal Scientific Reports (Nature Portfolio) that used advanced lipidomics analysis to peer deep into the blood of fasting individuals. What they found reads like a medical miracle: after just 29-30 days of Ramadan intermittent fasting (RIF), participants showed dramatic improvements in inflammatory markers and beneficial changes in complex lipids called sphingolipids that are directly linked to heart disease risk.
The study, which followed 57 overweight and obese adults (70% male, average age 38) in the United Arab Emirates, represents some of the most detailed metabolic analysis ever conducted on Ramadan fasting. Using liquid chromatography-mass spectrometry — a sophisticated technique that can identify and measure hundreds of different fat molecules in the blood — researchers mapped changes that could revolutionize how we understand fasting’s health benefits.
The Obesity Crisis and the Fasting Solution
Obesity has become one of the most pressing public health challenges of the 21st century. According to the World Health Organization, overweight and obesity contribute to more deaths worldwide than underweight. The condition is linked to a host of cardiometabolic problems including heart disease, type 2 diabetes, and non-alcoholic fatty liver disease — all driven in part by chronic low-grade inflammation.
“Systemic low-grade inflammation is a common underlying factor in the development of obesity and the subsequent affluent cardiometabolic diseases that are now prevalent,” the researchers explain.
Enter Ramadan fasting: a month-long period during which observant Muslims abstain from food, drink (including water), smoking, and sexual activity from dawn until sunset. The daily fasting duration in this study was approximately 15 hours — a form of time-restricted eating that has attracted enormous scientific interest in recent years.
What makes this study unique is its focus on sphingolipids — a class of lipids (fats) that have emerged as critical players in metabolic health. “Sphingolipid metabolism has a vital role in the regulation of inflammatory signaling pathways in the human body by working as the second messenger that propagates the inflammatory response,” the authors note.
What the Science Shows: Remarkable Improvements
The results of the study are striking. After just one month of Ramadan fasting, participants showed significant improvements across multiple health markers.
Table 1: Key Anthropometric Changes After Ramadan Intermittent Fasting
| Measurement | Before Ramadan | After Ramadan | Change | Significance |
|---|---|---|---|---|
| Body Weight (kg) | 88.32 ± 16.24 | 86.73 ± 15.74 | -1.59 kg | p = 0.001 |
| Body Mass Index (kg/m²) | 29.89 ± 5.02 | 29.40 ± 4.94 | -0.49 | p = 0.001 |
| Body Fat Percent | 29.51% ± 7.09% | 28.58% ± 7.34% | -0.93% | p = 0.001 |
| Fat Mass (kg) | 26.51 ± 9.49 | 25.25 ± 9.40 | -1.26 kg | p = 0.001 |
| Waist Circumference (cm) | 98.64 ± 13.69 | 97.23 ± 13.03 | -1.41 cm | p < 0.05 |
| Hip Circumference (cm) | 110.08 ± 9.46 | 108.55 ± 8.87 | -1.53 cm | p < 0.05 |
But the changes went far beyond simple weight loss. When researchers analyzed blood samples, they found remarkable improvements in markers of cardiovascular health.
Table 2: Improvements in Blood Markers After Ramadan Fasting
| Measurement | Direction of Change | Health Implication |
|---|---|---|
| LDL Cholesterol (“bad” cholesterol) | ↓ 5.2% | Reduced heart disease risk |
| HDL Cholesterol (“good” cholesterol) | ↑ 8.3% | Improved cardiovascular protection |
| Total Triglycerides | ↓ 7.1% | Better metabolic health |
| Total Diglycerides | ↓ 12.4% | Reduced fat storage signals |
| IL-6 (pro-inflammatory) | ↓ 31.2% | Less inflammation |
| TNF-α (pro-inflammatory) | ↓ 24.7% | Less inflammation |
| IL-10 (anti-inflammatory) | ↑ 41.3% | Enhanced immune regulation |
All changes statistically significant at p ≤ 0.05
The Sphingolipid Story: A New Frontier in Health
Perhaps most exciting is what the study revealed about sphingolipids — complex fat molecules that scientists now recognize as key players in heart disease, diabetes, and metabolic disorders.
“Ceramides and other sphingolipids as drivers of cardiovascular disease,” the researchers note, citing previous work showing that these molecules are directly involved in the development of heart problems.
The Ramadan fasting intervention produced significant reductions in multiple harmful sphingolipid species:
- Sphingosine: Decreased significantly (p ≤ 0.001)
- Sphinganine: Decreased significantly (p ≤ 0.001)
- Sphingosine-1-phosphate (S1P): Decreased significantly (p ≤ 0.001)
- Sphinganine-1-phosphate (Sa1P): Decreased significantly (p ≤ 0.001)
Specific sphingomyelin species (C17, C22, and C24) also showed significant reductions, as did multiple dihydrophingomyelin species (C20, C22, C24, and C24:1).
Why does this matter? These lipid species are not just passive markers — they’re active participants in disease processes. Elevated ceramides, for example, are known to “improve insulin resistance and hepatic steatosis” when targeted therapeutically. In plain language, high levels of these fats make it harder for your body to respond to insulin and contribute to fatty liver disease.
The fact that Ramadan fasting reduced multiple harmful lipid species simultaneously suggests a broad, systemic benefit that no single drug can match.
Inflammation: The Hidden Enemy
Modern medicine has increasingly recognized that chronic, low-grade inflammation is a common thread linking obesity, heart disease, diabetes, and even dementia. When the body’s immune system remains constantly activated at a low level, it slowly damages tissues and organs over years and decades.
The Ramadan fasting study showed dramatic effects on inflammatory markers:
- IL-6 (interleukin-6), a pro-inflammatory cytokine, decreased significantly (p = 0.001)
- TNF-α (tumor necrosis factor-alpha), another powerful inflammatory signal, decreased significantly (p = 0.001)
- IL-10 (interleukin-10), an anti-inflammatory cytokine that helps calm immune responses, increased significantly (p = 0.001)
This pattern — decreasing “bad” inflammation while increasing “good” anti-inflammatory signals — is exactly what clinicians hope to achieve with lifestyle interventions. The fact that it occurred after just one month of fasting is remarkable.
Why This Study Is Different
Previous research on Ramadan fasting has documented weight loss and improvements in traditional risk factors like cholesterol. But this study goes much deeper.
“This is the first study with a sufficient sample size using high accuracy LC-MS machine on fresh blood samples,” the researchers emphasize. LC-MS (liquid chromatography-mass spectrometry) allows scientists to identify and measure hundreds of different fat molecules simultaneously, providing a comprehensive picture of metabolic changes that was impossible just a few years ago.
The study design was also rigorous. Each participant served as their own control, with measurements taken before Ramadan and again at the end of the fasting month. This eliminates the problem of trying to match different groups of people who might have different baseline characteristics.
What About Diet?
One might wonder whether the benefits came simply from eating less or differently during Ramadan. The researchers tracked dietary intake carefully and found interesting patterns.
Encouraging changes:
- Protein intake decreased (from 108g to 98g per day, p = 0.002)
- Dietary cholesterol decreased dramatically (from 396mg to 273mg per day, p = 0.001)
- Vitamin C intake increased (from 74mg to 97mg per day, p = 0.006)
- Omega-3 fatty acids increased nearly threefold (from 0.66g to 1.82g per day, p = 0.001)
- Lycopene (a powerful antioxidant) increased nearly fourfold (p = 0.048)
Less encouraging changes:
- Sugar intake increased significantly (from 66g to 108g per day, p = 0.001)
The increase in sugar consumption reflects the traditional practice of breaking the fast with sweet foods, including dates — which the Prophet Muhammad himself recommended. “Eating simple sugars in the form of sweet palm dates is part of the prophetic guidance,” the researchers note.
Despite this increase in sugar intake, the overall metabolic improvements were still dramatic — suggesting that the benefits of fasting may outweigh even some unfavorable dietary changes.
How Long Do the Benefits Last?
An important question for anyone considering fasting for health benefits is whether the improvements persist. The researchers note that previous studies have shown “anthropometric and biochemical alterations resulting from Ramadan fasting can persist for up to one month following the conclusion of the fasting period.”
This suggests that the benefits are not merely temporary but may have lasting effects on metabolism and health.
Why This Matters for the 1.8 Billion Muslims Worldwide
With an estimated 1.8 billion Muslims globally, Ramadan represents the largest recurring fasting event in the world. Understanding its health effects has enormous public health implications.
For overweight and obese individuals — who make up a growing percentage of populations in both Muslim-majority and Muslim-minority countries — Ramadan may offer a structured, culturally appropriate, and cost-effective way to improve metabolic health.
The researchers conclude that Ramadan intermittent fasting “may impose short-term protection against cardiometabolic problems, and may be applied as a suggested cost-effective, health-improving, and cardiometabolic disease-preventing strategy for people with overweight and obesity.”
What This Means for Non-Muslims
While the study focused on Ramadan fasting, its implications extend to the broader field of intermittent fasting research. Time-restricted eating — limiting food consumption to a specific window each day — has become enormously popular as a health and weight loss strategy.
This study provides some of the most detailed metabolic evidence to date that such approaches can produce profound changes in lipid metabolism and inflammation. The fact that these changes occurred in overweight and obese individuals — precisely the population most in need of metabolic improvement — makes the findings particularly relevant.
The Bigger Picture: Fasting as Medicine
The concept of using fasting as medicine is ancient, appearing in medical traditions from Greek antiquity to traditional Chinese medicine. Modern science is now catching up, revealing the molecular mechanisms that explain why fasting can be therapeutic.
This study adds to a growing body of evidence showing that intermittent fasting:
- Improves insulin sensitivity
- Reduces inflammation
- Promotes beneficial changes in lipid metabolism
- Supports healthy weight loss
- May protect against chronic disease
What makes the Ramadan model particularly interesting is its combination of fasting with spiritual practice and community support. The social and psychological dimensions of Ramadan — increased prayer, charity, and community gathering — may amplify the physical benefits in ways that secular fasting protocols cannot replicate.
Limitations and Future Research
The researchers acknowledge several limitations to their study. The observational design means they cannot prove causation definitively, though the before-and-after measurements strengthen the case. The use of memory-based dietary assessment (24-hour recall) may introduce some inaccuracies. And the study population was limited to the United Arab Emirates, so results may not generalize to all populations.
Future research could explore whether similar benefits occur in different ethnic groups, whether the effects persist with repeated annual fasting, and what specific molecular mechanisms drive the observed changes.
Practical Takeaways
For Muslims preparing for Ramadan, the study offers encouragement that the physical benefits of fasting align with its spiritual purposes. For healthcare providers, it suggests that supporting patients who wish to fast during Ramadan may be beneficial rather than concerning — even for those with overweight and obesity.
For researchers, it opens new avenues for understanding how intermittent fasting affects metabolism at the molecular level. The sphingolipid changes documented here point to mechanisms that could be targeted therapeutically in the future.
Conclusion: A Month That Heals
For centuries, Muslims have experienced Ramadan as a time of spiritual renewal. Now science is revealing that the month also offers profound physical healing — reducing inflammation, improving cholesterol, and reshaping the lipid landscape in ways that protect against heart disease and metabolic dysfunction.
As the researchers note, these findings suggest that Ramadan intermittent fasting “may be applied as a suggested cost-effective, health-improving, and cardiometabolic disease-preventing strategy.”
Reference: here
Other Articles:
